+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 40Years - 80Years
All Genders
ID06878417

Study of Oral Cannabis Extracts CBD and THC for Pain Relief in Hip and Knee Osteoarthritis in Adults Aged 40 to 80

Led by University Health Network, Toronto · Updated on 2026-07-16

100

Participants Needed

3

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether oral cannabis extracts can help manage pain caused by osteoarthritis OA, a common joint disease affecting many people and leading to pain, stiffness, and swelling. This study focuses on evaluating two cannabis compounds, cannabidiol CBD and tetrahydrocannabinol THC, compared to a placebo, to see if they affect pain interference in patients with hip andor knee OA. The study also aims to test the feasibility of a larger trial by assessing patient enrollment, adherence, and data completeness. Participants will be randomly assigned to one of three groups receiving either CBD capsules 50 mg per capsule, THC capsules 3 mg per capsule, or placebo capsules daily for 8 weeks. Dosing will start with one capsule per day and may be gradually increased over the first four weeks based on patient response, up to a maximum of five capsules daily. After the 8-week treatment, participants who discontinue the study products will enter a tapering phase with follow-up visits, while those continuing cannabis use will receive support to obtain their own supply. Throughout the study, participants will complete remote follow-ups at weeks 1, 2, 3, 4, 6, and 8 to discuss treatment effects and side effects, complete questionnaires about pain, physical function, sleep, anxiety, depression, and quality of life, and maintain a diary tracking study drug use and any additional pain medications. After the 8-week treatment, unblinding will occur, and further monitoring will continue during tapering if applicable. The entire study is conducted remotely, requiring no in-person clinic visits, with a total participation duration of about 12 weeks including tapering.

CONDITIONS

Brief Title

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

Research Team

S

Sonal Thaker

D

Deep Grewal

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here